• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型神经肽孤啡肽未能产生条件性位置偏爱或厌恶。

The novel neuropeptide orphanin FQ fails to produce conditioned place preference or aversion.

作者信息

Devine D P, Reinscheid R K, Monsma F J, Civelli O, Akil H

机构信息

Mental Health Research Institute, University of Michigan, Ann Arbor 48109-0720, USA.

出版信息

Brain Res. 1996 Jul 15;727(1-2):225-9. doi: 10.1016/0006-8993(96)00476-3.

DOI:10.1016/0006-8993(96)00476-3
PMID:8842403
Abstract

An unbiased conditioned place preference procedure was used to determine whether the newly-identified neuropeptide orphanin FQ produced motivational effects after intracerebroventricular microinjections. Microinjections of orphanin FQ (0.1-100 nmol) failed to produce conditioned place preference or aversion, but a pronounced motor impairment was observed during conditioning sessions with the two highest doses. Thus, it appears that orphanin FQ lacks motivational effects when administered at behaviourally active doses.

摘要

采用无偏倚条件性位置偏爱程序来确定新发现的神经肽孤啡肽在脑室内微量注射后是否产生动机效应。微量注射孤啡肽(0.1 - 100纳摩尔)未能产生条件性位置偏爱或厌恶,但在使用两个最高剂量进行条件反射训练期间观察到明显的运动障碍。因此,当以行为活性剂量给药时,孤啡肽似乎缺乏动机效应。

相似文献

1
The novel neuropeptide orphanin FQ fails to produce conditioned place preference or aversion.新型神经肽孤啡肽未能产生条件性位置偏爱或厌恶。
Brain Res. 1996 Jul 15;727(1-2):225-9. doi: 10.1016/0006-8993(96)00476-3.
2
Central administration of nociceptin/orphanin FQ blocks the acquisition of conditioned place preference to morphine and cocaine, but not conditioned place aversion to naloxone in mice.向小鼠中枢给予孤啡肽/痛敏肽可阻断对吗啡和可卡因的条件性位置偏爱习得,但不影响对纳洛酮的条件性位置厌恶。
Psychopharmacology (Berl). 2004 Mar;172(2):129-36. doi: 10.1007/s00213-003-1643-3. Epub 2003 Nov 18.
3
Orphanin FQ/nociceptin blocks acquisition of morphine place preference.孤啡肽/痛敏肽阻断吗啡位置偏爱效应的获得。
Brain Res. 1999 Jun 19;832(1-2):168-70. doi: 10.1016/s0006-8993(99)01425-0.
4
Expression of morphine-conditioned place preference is more vulnerable than naloxone-conditioned place aversion to disruption by nociceptin in mice.在小鼠中,与纳洛酮条件性位置厌恶相比,吗啡条件性位置偏好的表达更容易受到孤啡肽的干扰。
Neurosci Lett. 2008 Oct 3;443(2):108-12. doi: 10.1016/j.neulet.2008.07.043. Epub 2008 Jul 22.
5
Nociceptin/orphanin FQ regulates neuroendocrine function of the limbic-hypothalamic-pituitary-adrenal axis.孤啡肽/痛敏肽调节边缘系统-下丘脑-垂体-肾上腺轴的神经内分泌功能。
Neuroscience. 2001;102(3):541-53. doi: 10.1016/s0306-4522(00)00517-0.
6
Effect of nociceptin/orphanin FQ on the rewarding properties of morphine.孤啡肽对吗啡奖赏特性的影响。
Eur J Pharmacol. 2000 Sep 15;404(1-2):153-9. doi: 10.1016/s0014-2999(00)00590-2.
7
Rats rapidly develop tolerance to the locomotor-inhibiting effects of the novel neuropeptide orphanin FQ.大鼠对新型神经肽孤啡肽的运动抑制作用迅速产生耐受性。
Neurochem Res. 1996 Nov;21(11):1387-96. doi: 10.1007/BF02532380.
8
Orphanin FQ is a functional anti-opioid peptide.
Neuroscience. 1996 Nov;75(2):333-7. doi: 10.1016/0306-4522(96)00338-7.
9
Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.甘氨酰谷氨酰胺,一种内源性β-内啡肽衍生肽,可抑制吗啡诱导的条件性位置偏爱、耐受性、依赖性和戒断反应。
J Pharmacol Exp Ther. 2005 Nov;315(2):949-58. doi: 10.1124/jpet.105.091553. Epub 2005 Aug 3.
10
Orphanin FQ acts as a supraspinal, but not a spinal, anti-opioid peptide.孤啡肽作为一种作用于脊髓以上水平而非脊髓水平的抗阿片肽。
Neuroreport. 1996 Sep 2;7(13):2125-9. doi: 10.1097/00001756-199609020-00012.

引用本文的文献

1
Pharmacological blockage of NOP receptors decreases ventral tegmental area dopamine neuronal activity through GABA receptor-mediated mechanism.对孤啡肽受体的药理学阻断通过γ-氨基丁酸(GABA)受体介导的机制降低腹侧被盖区多巴胺神经元的活性。
Neuropharmacology. 2024 May 1;248:109866. doi: 10.1016/j.neuropharm.2024.109866. Epub 2024 Feb 15.
2
Endogenous opioid systems alterations in pain and opioid use disorder.疼痛与阿片类物质使用障碍中的内源性阿片系统改变
Front Syst Neurosci. 2022 Oct 19;16:1014768. doi: 10.3389/fnsys.2022.1014768. eCollection 2022.
3
The NOP Receptor System in Neurological and Psychiatric Disorders: Discrepancies, Peculiarities and Clinical Progress in Developing Targeted Therapies.
神经精神疾病中的 NOP 受体系统:在开发靶向治疗方法中的差异、特点和临床进展。
CNS Drugs. 2021 Jun;35(6):591-607. doi: 10.1007/s40263-021-00821-0. Epub 2021 May 31.
4
Crosstalk between Opioid and Anti-Opioid Systems: An Overview and Its Possible Therapeutic Significance.阿片系统与抗阿片系统的串扰:概述及其可能的治疗意义。
Biomolecules. 2020 Sep 28;10(10):1376. doi: 10.3390/biom10101376.
5
Differential Modulation of Ventral Tegmental Area Circuits by the Nociceptin/Orphanin FQ System.孤啡肽/强啡肽系统对腹侧被盖区回路的差异调节。
eNeuro. 2020 Oct 19;7(5). doi: 10.1523/ENEURO.0376-19.2020. Print 2020 Jul/Aug.
6
NOP receptor agonist attenuates nitroglycerin-induced migraine-like symptoms in mice.NOP 受体激动剂可减轻小鼠硝化甘油诱导的偏头痛样症状。
Neuropharmacology. 2020 Jun 15;170:108029. doi: 10.1016/j.neuropharm.2020.108029. Epub 2020 Mar 6.
7
A Motivational and Neuropeptidergic Hub: Anatomical and Functional Diversity within the Nucleus Accumbens Shell.一个激励和神经肽枢纽:伏隔核壳内的解剖和功能多样性。
Neuron. 2019 May 8;102(3):529-552. doi: 10.1016/j.neuron.2019.03.003.
8
NOP Receptor Agonist Ro 64-6198 Decreases Escalation of Cocaine Self-Administration in Rats Genetically Selected for Alcohol Preference.NOP受体激动剂Ro 64-6198可降低对酒精有偏好的基因选择大鼠中可卡因自我给药的递增情况。
Front Psychiatry. 2019 Mar 29;10:176. doi: 10.3389/fpsyt.2019.00176. eCollection 2019.
9
Effects of NOP-Related Ligands in Nonhuman Primates.NOP相关配体在非人灵长类动物中的作用。
Handb Exp Pharmacol. 2019;254:323-343. doi: 10.1007/164_2019_211.
10
The Nociceptin Receptor (NOP) Agonist AT-312 Blocks Acquisition of Morphine- and Cocaine-Induced Conditioned Place Preference in Mice.孤啡肽受体(NOP)激动剂AT-312可阻断小鼠吗啡和可卡因诱导的条件性位置偏爱形成。
Front Psychiatry. 2018 Nov 29;9:638. doi: 10.3389/fpsyt.2018.00638. eCollection 2018.